RSA Talent Equity® | 2nd Annual Successful Biotech Boards
The RSA Group has published the latest of its Talent Equity® Reports, the second annual report analysing the performance of biotech Boards, CEOs and Chairs in Europe and the USA.
As Executive Chairman Nick Stephens explains: “Our goal was to bring insights that can be used in data-driven decision support, vital for building, assessing and refreshing Boards. Better leadership planning can help ensure the best return on technology and capital.
For people running public companies or private companies with public ambitions, there is a responsibility to patients and shareholders to ensure that the Board is as effective as it can possibly be. We believe that the new information uncovered by our research can play an important role in contributing to the success of biotech companies and in doing so, change patients’ lives”.